Veracyte SVP sells 6,466 shares at $40; 82,973 held after
Veracyte (VCYT) reported an insider transaction by its SVP, General Counsel.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Veracyte (VCYT) reported an insider transaction by its SVP, General Counsel. On 11/05/2025, the officer sold 6,466 shares of common stock at $40 per share, coded as an open market sale (S). Following the sale, the reporting person beneficially owned 82,973 shares, held directly. The filing notes the trades were made pursuant to a Rule 10b5-1 trading plan adopted on September 4, 2024.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,466 | $40.00 | $259K |
Footnotes (1)
- F1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VCYT disclose?
Who is the reporting person in the VCYT Form 4?
Was the VCYT sale under a 10b5-1 plan?
What does transaction code 'S' mean in the VCYT Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.